ARCHIVES

In Brief: HHS Won’t Nominate Fischbach for NIH; Kirschstein in Charge

This article is from The Cancer Letter archive.

Vol. 26 No. 17 | April 28, 2000

Download PDF Visit The Full Archive

Related Articles

Retraction Based On Data Given To Duke Last November, But Apparently Disregarded

October 29, 2010

Cancer Training Programs Fairing Fairley Well

December 1, 1989

FDA, Genentech Agree On Framework for Avastin Hearing June 28-29

April 8, 2011

In Congress: Senate Passes Bill For DOD Medical Research Funding

August 14, 1998

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

NCI Considering Adoption Of NIGMS Guidelines To Limit Growth Of Renewals, Ensure New Grants

November 30, 1990